Inhibitors of PFKFB3 for cancer therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9492418
APP PUB NO 20120302631A1
SERIAL NO

13467764

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds used to inhibit glycolytic pathway small molecule kinase 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase (PFKFB) are set forth; these inhibitors can be used in the treatment of certain diseases in which cells or tumors rely on glycolytic metabolism, such as many cancer cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGEOFFICE OF INNOVATION & ECOSYSTEM DEVELOPMENT INNOVATION & TECHNOLOGY COMMERCIALIZATION LOUISIANA STATE UNIVERSITY 8000 INNOVATION PARK DRIVE BATON ROUGE LA 70820

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Jeong Do Baton Rouge, US 2 13
Lee, Yong-Hwan Baton Rouge, US 35 490

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 15, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00